A nationwide survey of the quality of antimalarials in retail outlets in Tanzania

PLoS ONE

Volumn 3, Issue 10, 2008, Pages

  Kaur, Harparkash ^a   Goodman, Catherine ^a   Thompson, Eloise ^a   Thompson, Katy Anne ^a   Masanja, Irene ^b   Kachur, S Patrick ^c   Abdulla, Salim ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b IFAKARA HEALTH INSTITUTE   (Tanzania)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTESUNATE; ARTESUNATE PLUS MEFLOQUINE; CHLOROQUINE; FANSIDAR; FOLIC ACID ANTAGONIST; HALOFANTRINE; MEFLOQUINE; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFAMETOXYDIAZINE; QUININE; SULFAMETOXYDIAZINE; UNCLASSIFIED DRUG;

ARTICLE; DRUG LABELING; DRUG MANUFACTURE; DRUG MARKETING; DRUG QUALITY; DRUG SCREENING; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEDICAL LITERATURE; QUALITY CONTROL; TABLET FORMULATION; TANZANIA; INFORMATION PROCESSING; STANDARD; TABLET;

ANTIMALARIALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DATA COLLECTION; TABLETS; TANZANIA;

EID: 54849437736     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003403     Document Type: Article

References (23)

1. Snow RW, Craig MH, Newton CRJC, Steketee RW (2003) The Public Health Burden of Plasmodium falciparum Malaria in Africa: Deriving the Numbers. Disease Control Priorities Project Working Paper No. 11. Bethesda Maryland: Fogarty International Center, National Institutes of Health.
2. WHO (1999) Counterfeit drugs: guidelines for the development of measures to combat counterfeit drugs. Geneva: WHO. pp 1-60.
3. WHO (2006) Counterfeit medicines. Fact sheet No 275, Revised February 2006.
4. Amin AA, Kokwaro GO (2007) Antimalarial drug quality in Africa. J Clin Pharm Ther 32: 429-440.
5. White N (1999) Antimalarial drug resistance and combination chemotherapy. Philosophical Transactions of the Royal Society of London B. pp 739-749.
6. Dondorp AM, Newton PN, Mayxay M, Van Damme W, Smithuis FM, et al. (2004) Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials. Trop Med Int Health 9: 1241-1246.
7. Goodman C, Brieger W, Unwin A, Mills A, Meek S, et al. (2007) Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved? Am J Trop Med Hyg 77: 203-218.
8. Newton PN, Fernandez FM, Plancon A, Mildenhall DC, Green MD, et al. (2008) A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia. PLoS Med 5: e32.
9. Goodman CA (2004) An economic analysis of the retail market for fever and malaria treatment in rural Tanzania: PhD Thesis, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, University of London.
10. Goodman C, Kachur SP, Abdulla S, Bloland P, Mills A (2007) Drug shop regulation and malaria treatment in Tanzania-why do shops break the rules, and does it matter? Health Policy Plan 22: 393-403.
11. Battersby A, Goodman C, Abondo C, Mandike R (2003) Improving the supply, distribution and use of antimalarial drugs by the private sector in Tanzania. London: Malaria Consortium. pp 1-106.
12. Hetzel M, Msechu J, Goodman C, Lengeler C, Obrist B, et al. (2006) Decreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania. Malar J 5.
13. Hanson K, Nathan R, Marchant T, Mponda H, Jones C, et al. (2008) Vouchers for scaling up insecticide-treated nets in Tanzania: Methods for monitoring and evaluation of a national health system intervention. BMC Public Health (in press).
14. The United States Pharmacopeia (2000) USP 27: The National Formulary: NF 22: by authority of the United States Pharmacopeial Convention, Inc., meeting at Washington, D.C., April 12-16.
15. Clinton Foundation and Government of Tanzania (2007) Tanzania Pilot ACT Subsidy: Report on Preliminary Findings, November 2007.
16. Tanzania National Coordinating Mechanism (2007) Global Fund Proposal Round 7-Malaria Component.
17. Basco LK (2004) Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication. Am J Trop Med Hyg 70: 245-250.
18. Braun M (2005) Quality assessment of antimalarial drugs purchased from various sources in Tanzania. Practical assignment as a part of the Diploma Degree in Pharmaceutical Sciences at the University of Basel: Swiss Tropical Institute.
19. Minzi OM, Moshi MJ, Hipolite D, Massele AY, Tomson G, et al. (2003) Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania. J Clin Pharm Ther 28: 117-122.
20. Risha PG, Shewiyo D, Msami A, Masuki G, Vergote G, et al. (2002) In vitro evaluation of the quality of essential drugs on the Tanzanian market. Tropical Medicine & International Health 7: 701-707.
21. Atemnkeng MA, De Cock K, Plaizier-Vercammen J (2007) Quality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR Congo. Trop Med Int Health 12: 68-74.
22. Bate R, Coticelli P, Tren R, Attaran A (2008) Antimalarial drug quality in the most severely malarious parts of Africa - a six country study. PLoS ONE 3: e2132.
23. Kachur SP, Black C, Abdulla S, Goodman C (2006) Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam. Malar J 5: 25.